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Since the original discovery by the Daugulis group (J. Am. Chem. 
Soc. 2005, 127, 13154), powerful bidentate directing groups 
such as 8-aminoquinoline and picolinamide auxiliaries have 
been widely used for the activation of both C(sp2)–H and 
C(sp3)–H bonds. In order to improve convenience and efficien-
cy of the method, the development of new types of bidentate 
directing groups has been the subject of intensive research in-
volving many research groups. Despite the impressive achieve-
ments in catalytic asymmetric C–H activation through instal-
lation of chiral auxiliaries, stereoselective functionalization of 
C(sp3)–H bonds controlled by chiral bidentate directing groups 
still remains elusive. The laboratory of Professor Sungwoo 
Hong at the Korea Advanced Institute of Science and Technol-
ogy (KAIST, Daejeon, Korea) has been particularly interested 
in selective C–H functionalization of medicinally important 
privileged structures. Professor Hong said: “We hypothesized 
that an appropriate chiral bidentate directing group embedd-
ed in the substrate could induce high levels of stereocontrol 
during C–H functionalization via a steric repulsion model. A 
range of chiral auxiliaries, such as ester, tetrazole, and amino 
acid amide groups, were investigated for feasibility as directing 
groups on C(sp3)–H arylation.” Intriguingly, revealed Professor 
Hong, the amino acid amide moiety was identified as the most 
efficient chiral bidentate directing group to achieve both high 
reactivity and diastereoselectivity. Systematic inve stigation of 
substrate-bound α-amino acid auxiliaries resulted in catalytic 
asymmetric C–H functionalization of cyclopro panes enabled 
by amino acid amide as chiral bidentate directing groups. 
Professor Hong explained: “Following the discovery that the 
N-unsubstituted CONH2 moiety was crucial for achieving both 
high reactivity and diastereoselectivity, we further explored 
the effect of steric bulk at the α-position of amino acid 
amides on the selectivity of the process. The use of an Ile-NH2 
auxiliary embedded in the substrate was able to provide ex-
cellent levels of asymmetric induction (diastereomeric ratio 
of up to 72:1) in the Pd(II)-catalyzed β-methylene C(sp3)–H 
bond activation of cyclopropanes and cross-coupling with aryl 
iodides. We proposed a plausible reaction mechanism in-
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Scheme 1 Amino acid auxiliary controlled asymmetric C–H functionalization of cyclopropanes
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volving Ile-NH2 auxiliary-controlled asymmetric C–H func-
tion alization in which a Pd(II)/Pd(IV) catalytic cycle is invoked 
(Scheme 1).” According to this mechanism, the cleavage of the 
C(sp3)–H bond on the cyclopropane ring through a concerted 
metalation deprotonation (CMD) process produces the palla-
dacycle complexes 1 and 1′ which may exist in equilibrium. 
The oxidative addition path that proceeds through transition 
state 2 is favored over the other pathways, thereby leading to 
the major stereoisomer. On the other hand, according to the 
authors, the oxidative addition process for insertion of aryl 
iodide into Pd complex 1′ appears to be less feasible because 
the R substituent and the methylene group of cyclopropane 
cause blocking of the top and bottom faces of 2′. Therefore, 
high levels of asymmetric induction could be achieved in the 
Pd(II)-catalyzed C(sp3)–H functionalization of cyclopropanes. 
“The directing group is removable and the hydrolysis of the 
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Scheme 2 Substrate scope
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amino acid amide group occurred smoothly to afford arylated 
cyclopropanecarboxylic acid with conservation of the stereo-
genic centers,” explained Professor Hong. “This study repre-
sents the first systematic investigation of substrate-bound 
α-amino acid amides as chiral bidentate directing groups in 
the asymmetric C(sp3)–H functionalization of cyclopropanes.”
“From a conceptual viewpoint, the ability of a substrate-
bound α-amino acid auxiliary to promote asymmetric C–H 
functionalization is intriguing because the amino acid moiety 
derived from readily available chiral pools plays not only the 
role as a bidentate directing group, but also as a chiral auxil-
iary to provide efficient stereocontrol during C(sp3)–H bond 
functionalization,” said Professor Hong. The efficient protocol 
demonstrated a broad substrate scope and permitted for se-
lective installation of a variety of substituted aryl groups on 
cyclopropanes (Scheme 2). 
Professor Hong continued: “Furthermore, we preliminar-
ily investigated the diastereoselective C–H alkynylation and 
observed that 1 reacted with a bromoalkyne under the same 
reaction conditions, resulting in the single diastereomer 2 
(Scheme 3).”  
This novel synthetic methodology has interesting poten tial 
applications since the cyclopropyl group is commonly found 
in many biologically active natural products. It is frequently 
used for structure–activity relationship studies in medicinal 
chemistry because of its unique steric and conformational 
properties. In particular, the rigidity of cyclopropane can be 
utilized as a conformationally restricting linker in medicinal 
chemistry to improve the binding activity in drug dis covery. 
Professor Hong concluded: “Developing efficient catalytic me-
thodologies for the functionalization of cyclopropane has re-
ceived special attention in recent years. This convenient and 
powerful synthetic tool allows for the rapid and diastereo-
selective installation of the aryl groups into the cyclopropane 
scaffolds for delivery of potent biomolecules.” 
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Scheme 3 Coupling with a bromoalkyne
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